127 related articles for article (PubMed ID: 11065215)
21. Oxytocin releases atrial natriuretic peptide from rat atria in vitro that exerts negative inotropic and chronotropic action.
Favaretto AL; Ballejo GO; Albuquerque-Araújo WI; Gutkowska J; Antunes-Rodrigues J; McCann SM
Peptides; 1997; 18(9):1377-81. PubMed ID: 9392839
[TBL] [Abstract][Full Text] [Related]
22. Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist.
MacCarthy PA; Grocott-Mason R; Prendergast BD; Shah AM
Circulation; 2000 Jan; 101(2):142-7. PubMed ID: 10637200
[TBL] [Abstract][Full Text] [Related]
23. Modulation of contractile force by endothelin receptors in porcine myocardial trabeculae.
Saetrum Opgaard O; Tom B; de Vries R; Edvinsson L; Saxena PR
Pharmacol Toxicol; 2000 Oct; 87(4):185-92. PubMed ID: 11097274
[TBL] [Abstract][Full Text] [Related]
24. Role of ET(B) receptors in local clearance of endothelin-1 in rat heart: studies with the antagonists PD 155080 and BQ-788.
Brunner F; Doherty AM
FEBS Lett; 1996 Nov; 396(2-3):238-42. PubMed ID: 8914994
[TBL] [Abstract][Full Text] [Related]
25. Trophic effect of angiotensin II in neonatal rat cardiomyocytes: role of endothelin-1 and non-myocyte cells.
Pönicke K; Heinroth-Hoffmann I; Becker K; Brodde OE
Br J Pharmacol; 1997 May; 121(1):118-24. PubMed ID: 9146895
[TBL] [Abstract][Full Text] [Related]
26. Enhanced endothelin(A) receptor-mediated calcium mobilization and contraction in organ cultured porcine coronary arteries.
Hill BJ; Katwa LC; Wamhoff BR; Sturek M
J Pharmacol Exp Ther; 2000 Nov; 295(2):484-91. PubMed ID: 11046079
[TBL] [Abstract][Full Text] [Related]
27. Endothelin-1 mediated inhibition of the acetylcholine-activated potassium current from rabbit isolated atrial cardiomyocytes.
Spiers JP; Kelso EJ; McDermott BJ; Scholfield CN; Silke B
Br J Pharmacol; 1996 Dec; 119(7):1427-37. PubMed ID: 8968552
[TBL] [Abstract][Full Text] [Related]
28. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
J Am Coll Cardiol; 2001 May; 37(6):1493-505. PubMed ID: 11345356
[TBL] [Abstract][Full Text] [Related]
29. Differential inhibition by TAK-044 of the inotropic effects of endothelin-1 and endothelin-3.
Yomogida S; Maruya J; Norota I; Ishii K; Endoh M
Eur J Pharmacol; 2004 May; 492(2-3):217-24. PubMed ID: 15178368
[TBL] [Abstract][Full Text] [Related]
30. Contractile and arrhythmic effects of endothelin receptor agonists in human heart in vitro: blockade with SB 209670.
Burrell KM; Molenaar P; Dawson PJ; Kaumann AJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):449-59. PubMed ID: 10604982
[TBL] [Abstract][Full Text] [Related]
31. Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism.
Verma S; Maitland A; Weisel RD; Li SH; Fedak PW; Pomroy NC; Mickle DA; Li RK; Ko L; Rao V
J Thorac Cardiovasc Surg; 2002 Jun; 123(6):1120-4. PubMed ID: 12063458
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic and inotropic effects of the endothelin A antagonist BQ-610 in vivo.
Beyer ME; Slesak G; Brehm BR; Hoffmeister HM
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S258-61. PubMed ID: 9595454
[TBL] [Abstract][Full Text] [Related]
33. Role of endothelin-1 receptor antagonists in vasoconstriction mediated by endothelin and other vasoconstrictors in human internal mammary artery.
He GW; Liu MH; Yang Q; Furnary A; Yim AP
Ann Thorac Surg; 2007 Nov; 84(5):1522-7. PubMed ID: 17954056
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of cardiovascular responses induced by endothelin-1 in the perfused rat heart.
Kusumoto K; Fujiwara A; Ikeda S; Watanabe T; Fujino M
Eur J Pharmacol; 1996 Jan; 296(1):65-74. PubMed ID: 8720478
[TBL] [Abstract][Full Text] [Related]
35. Positive inotropic effect of endothelin-1 in the neonatal mouse right ventricle.
Nagasaka T; Izumi M; Hori M; Ozaki H; Karaki H
Eur J Pharmacol; 2003 Jul; 472(3):197-204. PubMed ID: 12871754
[TBL] [Abstract][Full Text] [Related]
36. The indirect negative inotropic effect of carbachol in beta1-adrenoceptor antagonist-treated human right atria.
Wangemann T; Giessler C; Willmy-Matthes P; Silber RE; Brodde OE
Eur J Pharmacol; 2003 Jan; 458(1-2):163-70. PubMed ID: 12498921
[TBL] [Abstract][Full Text] [Related]
37. Endothelin receptors in the failing and nonfailing human heart.
Pönicke K; Vogelsang M; Heinroth M; Becker K; Zolk O; Böhm M; Zerkowski HR; Brodde OE
Circulation; 1998 Mar; 97(8):744-51. PubMed ID: 9498537
[TBL] [Abstract][Full Text] [Related]
38. Significance of the endothelin ETA receptor in the haemodynamic and inotropic effects of endothelin-1 in rats.
Beyer ME; Hövelborn T; Delabar U; Hoffmeister HM
Clin Sci (Lond); 2004 Nov; 107(5):467-75. PubMed ID: 15233620
[TBL] [Abstract][Full Text] [Related]
39. Effect of endothelin antagonists, including the novel ET(A) receptor antagonist LBL 031, on endothelin-1 and lipopolysaccharide-induced microvascular leakage in rat airways.
Hele DJ; Birrell MA; Webber SE; Foster ML; Belvisi MG
Br J Pharmacol; 2000 Nov; 131(6):1129-34. PubMed ID: 11082120
[TBL] [Abstract][Full Text] [Related]
40. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
